Evaluating the effectiveness of local application of blood products mixed zinc oxide in the treatment of gum disease

Clinical efficacy of locally delivered zinc oxide loaded iPrf in the treatment of Intrabony periodontal defect - A Randomized Controlled Trial - NIL

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072377

Enrollment

Registered

2024-08-12

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: Group 1 - local drug delivery of zinc oxide loaded iPrf : After phase 1 periodontal therapy, this group will be treated with zinoxide loaded iPRF for localised intrabony defect. The iPR

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient with periodontitis with angular Intra bony defect

Exclusion criteria

Exclusion criteria: Patients with habits,like smoking, tobacco chewing or alcohol consumption,having uncontrolled diabetes,hypertension or immunocompromised conditions, pregnant women or lactating mothers, noncompliant or physically challenged people, and those who were not able to maintain oral hygiene or be followed up at a recall visit

Design outcomes

Primary

Measure	Time frame
Probing depth, Clinical Attachment Level, radiologic assessment of Intra bony defect fill (CBCT)Timepoint: Baseline, 3 months, 6 months , 9 months	—

Secondary

Measure	Time frame
Osteonectin levelsTimepoint: Baseline, 3 months	—

Countries

India

Contacts

Public ContactPoulami Chakraborty

Saveetha Dental College and Hospital

Thamaraiselvanperiodontics@gmail.com9884276922

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026